IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer
British Journal of Surgery · 2023
DOI: 10.1093/bjs/znad219 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, 2023. Verfasst von Gaya Spolverato und 59 weiteren Autor:innen. Beteiligte Einrichtung: UOC Chirurgia Generale 3, Azienda Ospedale-Università Padova, Padua, Italy. Hauptthemen laut MEDLINE: Rectal Neoplasms, Adenocarcinoma, Immunologic Surveillance. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Gefördert von: AIRC Investigator, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Background
Colon cancer in young patients is often associated with hereditary syndromes; however, in early-onset rectal cancer, mutations of these genes are rarely observed. The aim of this study was to analyse the features of the local immune microenvironment and the mutational pattern in early-onset rectal cancer.
Methods
Commonly mutated genes were analysed within a rectal cancer series from the University Hospital of Padova. Mutation frequency and immune gene expression in a cohort from The Cancer Genome Atlas (‘TCGA’) were compared and immune-cell infiltration levels in the healthy rectal mucosa adjacent to rectal cancers were evaluated in the IMMUNOlogical microenvironment in REctal AdenoCarcinoma Treatment 1 and 2 (‘IMMUNOREACT’) series.
Results
In the authors’ series, the mutation frequency of BRAF, KRAS, and NRAS, as well as microsatellite instability frequency, were not different between early- and late-onset rectal cancer. In The Cancer Genome Atlas series, among the genes with the most considerable difference in mutation frequency between young and older patients, seven genes are involved in the immune response and CD69, CD3, and CD8β expression was lower in early-onset rectal cancer. In the IMMUNOlogical microenvironment in REctal AdenoCarcinoma Treatment 1 and 2 series, young patients had a lower rate of CD4+ T cells, but higher T regulator infiltration in the rectal mucosa.
Conclusion
Early-onset rectal cancer is rarely associated with common hereditary syndromes. The tumour microenvironment is characterized by a high frequency of mutations impairing the local immune surveillance mechanisms and low expression of immune editing-related genes. A constitutively low number of CD4 T cells associated with a high number of T regulators indicates an imbalance in the immune surveillance mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UOC Chirurgia Generale 3, Azienda Ospedale-Università Padova, Padua, Italy.
- Department of Medicine DIMED, University of Padua, Padua, Italy.
- Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
- Immunology and Molecular Oncology Diagnostics Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
- Surgical Oncology of Digestive Tract Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
- Chirurgia ad indirizzo oncologico, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
ORCID-Profile: Gaya Spolverato, Matteo Fassan, Melania Scarpa, Ottavia De Simoni, Federico Scognamiglio, Imerio Angriman, Andromachi Kotsafti, Cesare Ruffolo, Maurizio Zizzo, Francesco Marchegiani, Francesca Bergamo, Gianluca Businello, Marco Massani, Tommaso Stecca, Angelo Paolo Dei Tos, Vittorina Zagonel, Pierluigi Pilati, Boris Franzato, Giovanni Pirozzolo, Monica Ortenzi, Marco Agostini, Isacco Maretto, Quoc Riccardo Bao, Francesco Cavallin, Barbara Di Camillo
Förderung
- AIRC Investigator
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Spolverato, G., Fassan, M., Scarpa, M., Stepanyan, A., De Simoni, O., Scognamiglio, F., Chiminazzo, V., De Nardi, C., Tamponi, G., Negro, S., Angriman, I., Kotsafti, A., Ruffolo, C., Vignotto, C., Zizzo, M., Marchegiani, F., Facci, L., Bergamo, F., Brignola, S., …, & Bardini, R. (2023). IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer. British Journal of Surgery. https://doi.org/10.1093/bjs/znad219
Vancouver
Spolverato G, Fassan M, Scarpa M, Stepanyan A, De Simoni O, Scognamiglio F, et al. IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer. British Journal of Surgery. 2023. doi:10.1093/bjs/znad219
BibTeX
@article{Spolverato2023,
author = {Spolverato, Gaya and Fassan, Matteo and Scarpa, Melania and Stepanyan, Astghik and De Simoni, Ottavia and Scognamiglio, Federico and Chiminazzo, Valentina and De Nardi, Clarissa and Tamponi, Giulia and Negro, Silvia and Angriman, Imerio and Kotsafti, Andromachi and Ruffolo, Cesare and Vignotto, Chiara and Zizzo, Maurizio and Marchegiani, Francesco and Facci, Luca and Bergamo, Francesca and Brignola, Stefano and Businello, Gianluca and Guzzardo, Vincenza and Dal Santo, Luca and Salmaso, Roberta and Ceccon, Carlotta and Massani, Marco and Pozza, Anna and Cataldo, Ivana and Stecca, Tommaso and Dei Tos, Angelo Paolo and Zagonel, Vittorina and Pilati, Pierluigi and Franzato, Boris and Scapinello, Antonio and Pirozzolo, Giovanni and Recordare, Alfonso and Merenda, Roberto and Bordignon, Giovanni and Laurino, Licia and Guerriero, Silvio and Romiti, Chiara and Portale, Giuseppe and Cipollari, Chiara and Candioli, Salvatore and Gavagna, Laura and Pozza, Giulia and Godina, Mario and Mondi, Isabella and Noaro, Giulia and Ortenzi, Monica and Guerrieri, Mario and Tagliente, Giovanni and Tomassi, Monica and Tedeschi, Umberto and Porzionato, Andrea and Agostini, Marco and Maretto, Isacco and Bao, Quoc Riccardo and Cavallin, Francesco and Di Camillo, Barbara and Bardini, Romeo},
title = {IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer},
journal = {British Journal of Surgery},
year = {2023},
doi = {10.1093/bjs/znad219}
}
EUVIMED